CNC vs KRRO · P/E 8.4, rev $163.07B vs rev $2.3M
Centene Corp (CNC) versus Korro Bio, Inc. (KRRO) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. KRRO currently screens at market cap $159.8M.
Not investment advice. Open the CNC and KRRO stock pages for the full models.
Not investment advice.